In exploratory analyses, BD‐tau concentrations were not correlated with the day of blood draw, and there was no significant difference observed in BD‐tau concentrations in first‐ever versus recurrent stroke (see Section S2 for details). The gene discussed is MAPT; the disease is stroke disorder.